some nervousness about integration issues, etc. Of course, that's always an issue but there are some really re-assuring statements in today's announcement which seems to reduce these risks materially:
- PGC and REM "... are very similar in structure, strategy and delivery"
- "... The vendors and executive management team will be remaining with the business throughout the earn-out period".
- reasonable earn-out period and incentives: every $ of EBITDA growth they get paid $4.5
- "The REM business has recorded strong organic growth over recent years in the range of 6% pa – 8% pa". so good momentum, not requiring new mgmt/strategy/change in focus etc. no need for PGC to step in
- "... REM’s commanding presence in the New Zealand healthcare market and valuable product lines provides opportunity to leverage the Paragon portfolio. REM is simply a fantastic spearhead investment into the New Zealand market".
all very re-assuring indeed. GLAH
Ann: Trading Halt, page-20
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PGC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
42.0¢ |
Change
-0.010(2.33%) |
Mkt cap ! $695.2M | |||
| Open | High | Low | Value | Volume |
| 42.5¢ | 42.5¢ | 41.0¢ | $1.013M | 2.435M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 200000 | 41.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 42.0¢ | 54906 | 2 |
View Market Depth
| Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
| PGC (ASX) Chart |